.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
US Army
Moodys
Colorcon
Harvard Business School
Fuji
Covington
UBS
Queensland Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

Adapt Company Profile

« Back to Dashboard

What is the competitive landscape for ADAPT, and when can generic versions of ADAPT drugs launch?

ADAPT has two approved drugs.

There are seven US patents protecting ADAPT drugs on ADAPT drugs in the past three years.

There are fourteen patent family members on ADAPT drugs in eleven countries and one supplementary protection certificate in one country.

Summary for Adapt

International Patents:14
US Patents:7
Tradenames:1
Ingredients:1
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AdaptNARCANnaloxone hydrochlorideSPRAY, METERED;NASAL208411-001Nov 18, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
AdaptNARCANnaloxone hydrochlorideSPRAY, METERED;NASAL208411-001Nov 18, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
AdaptNARCANnaloxone hydrochlorideSPRAY, METERED;NASAL208411-001Nov 18, 2015RXYesYes► Subscribe► Subscribe► Subscribe
AdaptNARCANnaloxone hydrochlorideSPRAY, METERED;NASAL208411-001Nov 18, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
AdaptNARCANnaloxone hydrochlorideSPRAY, METERED;NASAL208411-001Nov 18, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
AdaptNARCANnaloxone hydrochlorideSPRAY, METERED;NASAL208411-002Jan 24, 2017RXYesNo► Subscribe► SubscribeY► Subscribe
AdaptNARCANnaloxone hydrochlorideINJECTABLE;INJECTION016636-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
AdaptNARCANnaloxone hydrochlorideINJECTABLE;INJECTION016636-003Jun 14, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
AdaptNARCANnaloxone hydrochlorideINJECTABLE;INJECTION016636-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
AdaptNARCANnaloxone hydrochlorideSPRAY, METERED;NASAL208411-002Jan 24, 2017RXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ADAPT drugs

Drugname Dosage Strength Tradename Submissiondate
naloxone hydrochlorideNasal Spray4 mg/sprayNARCAN7/15/2016

International Patent Family for Adapt Drugs

Country Document Number Estimated Expiration
United Kingdom201616616► Subscribe
United Kingdom2538682► Subscribe
Spain2631504► Subscribe
European Patent Office3116478► Subscribe
Japan2017508800► Subscribe
Germany112015001251► Subscribe
Canada2942611► Subscribe
Mexico2016011902► Subscribe
Canada2950687► Subscribe
Australia2015228541► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Adapt Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Colorcon
QuintilesIMS
Harvard Business School
Boehringer Ingelheim
Argus Health
Baxter
Accenture
Fuji
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot